- Home
- TRT vs HUMA Comparison
TRT vs HUMA Comparison
Compare TRT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRT | HUMA |
|---|---|---|
| Founded | 1958 | 2004 |
| Country | United States | United States |
| Employees | N/A | 184 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.8M | 155.4M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRT | HUMA |
|---|---|---|
| Price | $14.04 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $6.19 |
| AVG Volume (30 Days) | 1.3M | ★ 6.3M |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $32,462,000.00 | N/A |
| Revenue This Year | N/A | $444.16 |
| Revenue Next Year | N/A | $248.39 |
| P/E Ratio | $834.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.42 | $0.55 |
| 52 Week High | $21.38 | $2.93 |
Technical Indicators
Market Signals| Indicator | TRT | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 62.71 |
| Support Level | $5.75 | $0.89 |
| Resistance Level | $14.78 | $1.28 |
| Average True Range (ATR) | 2.63 | 0.13 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 32.17 | 82.93 |
Price Performance
Historical ComparisonAbout TRT Trio-Tech International
Trio-Tech International is a provider of reliability test equipment and services to the semiconductor and other industries. Its customers are from automotive electronics, industrial electronics, computing and data storage, consumer electronics, and communication markets. The company operated its business in two segments: Semiconductor Back-end Solutions and Industrial Electronics. Geographically, the company operates in the United States (U.S), Singapore, Malaysia, Thailand and China.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.